Clinical Trials Directory

Trials / Terminated

TerminatedNCT01983085

Nitric Oxide Generating Gel Dressing in Patients With Superficial Partial Thickness Wounds

ProNOx 2 - A Clinical Study of Superficial Partial Thickness Wound Treatment With an Oxides of Nitrogen Generating Gel Dressing

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Edixomed Ltd · Industry
Sex
All
Age
1 Year
Healthy volunteers
Not accepted

Summary

This is a study to assess the safety and efficacy of a nitric oxide (NOx) generating dressing on superficial partial thickness (SPT) wounds. Nitric oxide has a range of effects on the body including vasodilation and angiogenesis. It is also a potent antimicrobial. This 160 patient, randomised, controlled clinical study will assess the ability of a simple 2 part, NOx generating dressing to improve healing in SPT burn wounds and SPT skin graft donor site wounds compared to standard of care.

Detailed description

This is a clinical study of a new wound dressing for superficial partial thickness (SPT) wounds. The dressing consists of 2 stable layers that when placed together release Nitric Oxide. In preclinical studies NOx delivery has caused significant vasodilation, angiogenesis and demonstrated potent anti-microbial activity. This is a multi-centre, 160 patient, randomised, controlled study. There are 2 arms to the study. 80 patients will have treatment applied to a SPT burn wound and 80 patients will have treatment applied to a SPT graft donor site wound. The controls will be intra-individual. Each patient will have their wound divided into 2, half of the wound being treated with the NOx dressing, the other half treated with standard of care. The positioning of the dressings will be randomised. The NOx dressing will be changed at least every 2 days and the standard of care changed according to normal clinical practice and patients will be treated until the wound is healed. The study will evaluate: * The size of the wound * Eepithelialisation * Trans-epidermal water loss * Infection status. There will be 3 and 12 month follow up with assessment of scarring.

Conditions

Interventions

TypeNameDescription
DEVICENOx dressingThe NOx dressing should be changed at least every 2 days.
DEVICEStandard of CareDressing changed as per normal clinical practice

Timeline

Start date
2013-09-01
Primary completion
2014-03-01
Completion
2014-05-01
First posted
2013-11-13
Last updated
2021-04-15

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01983085. Inclusion in this directory is not an endorsement.